MktsMarkets

Artiva Biotherapeutics, Inc.
NASDAQ: ARTVKey statistics
ARTV News
Stories mentioning ARTV from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Operating Expenses | ||||||||
| Research & Development | 19,312 | 16,994 | 17,633 | 17,861 | 17,052 | 13,315 | 13,524 | 12,333 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 24,430 | 21,932 | 22,897 | 22,810 | 22,171 | 18,265 | 18,335 | 16,190 |
| Operating Income (Loss) | (24,430) | (21,932) | (22,897) | (22,810) | (22,171) | (18,265) | (18,335) | (16,190) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 2.00 | (2.00) | (3.00) | (5.00) | (4.00) | (7.00) | (6.00) | 23.00 |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (23,516) | (20,772) | (21,528) | (21,254) | (20,311) | (16,095) | (17,472) | (17,843) |
| Earnings Per Share (Basic) | (0.95) | (0.85) | (0.88) | (0.87) | (0.83) | (1.43) | (0.92) | (22.00) |
| Earnings Per Share (Diluted) | (0.95) | (0.85) | (0.88) | (0.87) | (0.83) | (1.43) | (0.92) | (22.00) |
| Weighted Average Shares Outstanding (Basic) | 24,678 | 24,444 | 24,482 | 24,379 | 24,342 | 11,259 | 18,897 | 811.00 |
| Weighted Average Shares Outstanding (Diluted) | 24,678 | 24,444 | 24,482 | 24,379 | 24,342 | 11,259 | 18,897 | 811.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ARTV
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARTV. It last traded at $3.83 (Nov 19, 2026, 4:00 PM ET), up 1.6% on the day. That gives Artiva Biotherapeutics a market capitalisation of $189.3M.
Over the past 52 weeks ARTV has traded between $2.96 and $14.53.
For the quarter ended Mar 31, 2026 it reported a net loss of $23.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$23.5M |
| Dec 31, 2025 | — | -$20.8M |
| Sep 30, 2025 | — | -$21.5M |
| Jun 30, 2025 | — | -$21.3M |
From Artiva Biotherapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…